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Introduction
Cellulose is a linear polysaccharide consisting of a chain of β (1-4) 
linked D-glucose units.1 Cellulose is the major component of wood 
and most natural fibers from vegetal kingdom. This natural polymer 
represents about a third of the plant tissues and can regenerate through 
photosynthesis.2 Although vegetable origin cellulose is widely applied 
at industrial level, the productive scale generates serious problems on 
ecosystems where the pulp mills mega industries known as “pasteras” 
are located.3 In emerging countries such as Argentina and Uruguay, 
the location of these “pasteras”, generates great concern. A report 
presented by Uruguay Republic University (UDELAR) on 2006, 
summarizes the available scientific evidence about environmental 
impacts of the installation of pulp mills and the associated forestry 
model.4 The report presents an analysis and studies of the effects of the 
forest crop on the ecosystem, benefits provided by the natural pastures, 
and the effects generated by the liquid effluents of the pasteras at 
hierarchical levels (molecular, individual, population, community and 
ecosystem).4 Traditionally the Kraft method is used to obtain vegetable 
cellulose.5 The numerous processes that make up the method, where 
each one contributes its share in the consumption of energy, chemical 
compounds and pollution, result in a clear disadvantage when it 
comes to thinking about sustainable processes.6 However, it’s wide 
variety of applications and its potential, led scientists from all over 
the world to look for sustainable and ecologically friendly options to 
obtain cellulose. There is a high potential even more to be discovered 
regarding materials from biological origin. Diverse applications of 
each new discovered material are the object of study by researchers 
from all over the world. This varied and exhaustive analysis resulted 
in the appearance of potential products with high added value and very 
low environmental impact.7 These cellulosic estructures are called 
Nan fibrillated Cellulose (NFC) and refers to cellulose fibers that have 
been fibrillated to achieve agglomerates of cellulose microfibril units; 
NFCs have nanoscale (less than 100nm) diameter and typical length of 
several micrometers.5 Several denominations exist for describing such 
material and most often Nano and Micro Fibrillated Cellulose (NFC/
MFC) are used.8 Mechanical disintegration is the method of choice for 
the Nan fibrillated cellulose. In this process it is possible to obtain a long 
and flexible nanocellulosic material.9 Following a sustainable trend, 
many alternatives emerge to obtain NFC whose source transcends 
wood cheeps. Vegetable residues from other industries such as, palms, 
bagasse, wheat straw and soybean residues, pulps among others, are 
now explored alternatives. In Argentina two main fonts are bagasse 
from sugar cane process and soy hulls.8 As it is known, cellulose 
can not only be obtained from plant sources. Recently, other ways 
beyond the plant kingdom have attracted attention. This new route for 
the production of micro and nano cellulose fibers opens a plethora of 
possibilities regarding applications and distinctive characteristics of 
the material that are currently studied.10 
This review presents the advances made in the alternative 
production of this material which, due to its broad advantages 
over other polymers, represents a sustainable, green and economic 
alternative to replace non-biodegradable products. The replacement of 
non-active pharmaceutical ingredients in the design of pharmaceutical 
formulations is a key issue in particular because as a raw material, 
cellulose already forms part of pharmacopoeias throughout the world, 
narrowing the gap between laboratory-scale studies and its production 
for commercialization. 
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Abstract
Nano Cellulose is commonly produced by the top-down enzymatic, mechanical and/
or chemical treatments. In contrast, Bacterial Nano Cellulose (BNC) can be obtained 
by a bottom-up approach, where is biosynthesized from glucose using the direct 
action of specific bacterial strains. BNC impart attractive combinations of biologic 
and physicochemical characteristics such as biocompatibility, biodegradability, 
light weight, sustainability, and improved mechanical properties. The trend towards 
environmental sustainability and development of renewable resources has significantly 
increased interest. A critical aspect in BNC production is to identify a low-cost culture 
medium that can improve the yield of BNC and can be used as an economically viable 
solution for application in a range of fields. There is an immense perspective of 
BNC in health care as well as drug applications. Potential uses include barrier films, 
antimicrobial films, pharmaceuticals and drug delivery systems. Even though BNC 
has been demonstrated as nongenotoxic and noncytotoxic, further studies are required 
to completely address such issue. Key aspects for future development include the 
design of BNC for specific user requirements, the reduction of production costs, and 
the customization/functionalization using post production steps and different types of 
compounding/processing.
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Bacterial Nano Cellulose
Cellulose is commonly produced with a desired size by the 
top-down enzymatic, mechanical and chemical treatments of 
cellulosic precursors, in which cotton, wood, annual plants or 
other agricultural residues can be used. In contrast, cellulose can 
be obtained by a bottom-up approach, where is biosynthesized 
from glucose using the direct action of specific bacterial strains.11 
Bacteria species such as Pseudomonas fluorecens, Gluconacetobacter 
xylinus, Gluconacetobacter hansenni produce cellulose as one of its 
metabolites. Gluconacetobacter xylinus is one of the first studied as 
Bacterial Nano Cellulose (BNC) producer and has become a model 
system for the study of the biosynthetic mechanisms of BNC.12 The 
mechanism of cellulose production by the bacterium G. xylinus is the 
construction of a interface air/culture medium film nanofiber.13,14 BNC 
is a primary metabolite synthesized in the interior of the bacterial cell 
that is later twisted into nanofibrils that is mechanically amplified to 
form micro fibrils.15,16 During biosynthesis of cellulose chains, van 
der Waals forces and hydrogen bonding between hydroxyl groups and 
oxygen of adjacent molecules promote parallel stacking of multiple 
cellulose chains forming elementary fibrils that further aggregate into 
larger microfibrils.17 BNC has distinctive characteristics due mainly 
to its size and fibrillar disposition that introduces modifications in its 
biological and physicochemical properties such as biocompatibility 
and biodegradability. In addition, the fibers are lighter, have greater 
optical transparency, their surface is chemically adaptable because 
it allows the annexation of multiple functional groups, enhancing 
their mechanical properties.18 Among the potentialities of BNC are 
some highly relevant pharmaceutical applications such as biomedical 
implants or scaffolds, translucent films, controlled release systems, 
antimicrobial dressings and patches with barrier action.19‒21 Enzymes 
immobilization, tissues engineering. Among the most interesting 
applications are bone, cartilage, corneas, artificial skin, and dental 
materials and implants.15 Also they exhibit high chemical resistance 
to dilute acids and alkalis solutions, organic solvents, proteolytic 
enzymes and antioxidants as well.11 Chemical modification of the 
cellulosic structure to improve interactions with living tissues could 
enlarge the utilization of nanocelluloses in biomedical devices 
tremendously. 
Biosynthesis a bottom-up approach
There are two fundamental methods for the production of bacterial 
nano cellulose developed so far: a) Static cultivation is useful when 
production in the form of a film is required. With this method, a 
monolayer of BNC of white color and variable thickness is obtained 
according to the incubation times and culture media composition, 
and b) Stirred cultivation, is useful when a dispersion or suspension 
of cellulose micro fibrils in the heart of the liquid is required. It can 
appear as fibers or conglomerates of irregular size.22 there are currently 
several methodologies for large-scale BNC production. Increasing the 
production efficiency is one of the main objectives for researchers and 
so far, results have been obtained that support the demand for BNC 
production at laboratory scale. However, it is necessary to satisfy a 
greater demand for the product and further improve the yields obtained, 
modifying the growth media, in order to reduce costs and increase 
productivity. Low cost medium that allows improving the yield of 
BNC could be a viable solution for the design of prototypes in a wide 
variety of fields of application. One of the cellulose producer bacteria 
is Pseudomonas fluorecens.23 these bacteria present a convenient 
behaviour as cellulose biofactorie. The space for cellulose attachment 
is between air and liquid interface, which when colonized, provides 
bacteria with access for both the gaseous (e.g. oxygen) and liquid (e.g. 
nutrient) phases.23 All so, these attachments facilitate its harvest from 
reactor surface, diminish handling errors and improve production 
recovery process. These main factors represent advantages thinking 
on scaling up process, but media commercial growing is expensive 
for industrial development. Previously, many authors reported the use 
of waste from other industries as a carbon source for the bacterial 
cellulose production.24‒26 however, although these practices are very 
interesting and useful, adds additional steps to the process of product 
purification. Organic and inorganic molecules as well as physical 
stressors are factors that positively or negatively affect the BNC 
synthesis. Then, the selected cultivation medium may also affect yield, 
structure, cohesiveness, crystallinity and amorphicity degree among 
other properties from BNC beyond the production method. Refined 
sugars and protein sources, although costly, are the most commonly 
used substrates for commercial production of metabolites by 
fermentation process.27 The trend towards environmental sustainability 
and development of renewable resources has significantly increased 
interest. A research team developed a new growing media designed 
as a clean production experience by recovering residual bacterial 
cell from Pseudomonas fluorecens. By redesigning a growth media 
for increase bacterial cellulose production replacing all protein and 
carbon sources for heat pre-treated residual bacterial cells.28,29 An 
interesting option in situ during growing static cultivation is that the 
cellulose-producing microorganisms can be grown in culture medium 
with some sources, such as fruit syrup, that allow to produce cellulose 
to acquire the nature flavor and pigment of the fruit. 30 There are still 
many options to explore in reference to top down production and 
research groups around the world are developing variants that confer 
distinctive characteristics to the BNC. They also offer pharmaceutical 
and chemical researchers and industrials many intellectual property 
opportunities.
Application as non-active pharmaceutical 
ingredient
Commercial and intellectual interests are steal focus on active 
pharmaceutical ingredients (APIs) like solid forms. The solid forms of 
a drug, which can be crystalline, co-crystalline, solvate or amorphous, 
can have different solubility, bioavailability, stability and processing 
characteristics.31 Its applicability results in an exhaustive study and 
a strong commercial interest in the investigation of pharmacological 
substances in solid state with respect to other types of molecules. The 
perspectives regarding the application of BNC in the field of health 
care, as well as in the design of new drugs are incalculable, particularly 
in this instance where the profiles of new drugs are advancing rapidly 
and the development of innovative pharmaceutical forms becomes 
in a technological need.32 Polymers like polystyrene, rubber, plastic, 
polyvinylchloride are used extensively in the pharmaceutical industry, 
for the manufacture of vials, closures, tubing, injection sets, flexible 
blood bags.33 originally the use was limited to primary packaging, 
secondary packaging and accessories, but they were not considered 
part of the pharmaceutical form. The development of pharmaceutical 
technology and the exploration of new drugs encouraged the 
symbiosis of polymer chemistry and pharmaceutical sciences. 
Cellulose derivatives have the advantage of easily accepting chemical 
surface modifications. These modifications confer characteristics such 
as biological compatibility, biodegradability, robustness and other 
features such as low production cost that make them the products 
of choice for the pharmaceutical industry.34 BNC represents a new 
perspective on non-active pharmaceutical ingredients, since it allow 
novel amphipathic chemical modifications. The cellulosic derivatives 
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are useful for the controlled release of drugs in solid formulations 
such as capsules and tablets. They also fulfil various functions in the 
technological development of solid pharmaceutical forms acting as 
non-active pharmaceutical ingredients and favouring the rheological 
characteristics in suspensions and emulsions.35 Methylcellulose (MC) 
is acts as diluent and disintegrating agent for API release on solid 
dosage forms.36 Hydrophilic matrix systems adopt hydroxypropyl 
cellulose (HPC), hydrophobic matrix system use often ethyl cellulose 
(EC). Also, liquid and semi-solid pharmaceutical dosage forms are 
important physicochemical systems for medical treatment which 
require rheological control and stabilizing excipients as essential 
additives, carboxymethyl cellulose (CMC),37 is use for adjust the 
syrups viscosity. Nan particles made up of polysaccharides and 
polysaccharide-attached derivatives are useful as vectors for active 
pharmaceutical ingredients (APIs) that require controlled release at 
the target site.38 these self-assembled nano-structures are produced 
from the modification of polysaccharides using amphiphilic molecules 
as the obtaining method. The amphiphilicity is necessary to complete 
the process of self-assembly property, since the monomers are 
assembled by modifying the hydrophobic/hydrophilic balance.39 The 
electrostatic interaction of ionic polysaccharides of opposite charges 
is another alternative for self-assembly.40 Chemical modification of the 
cellulosic structure to improve interactions with living tissues could 
enlarge the utilization of BNC in biomedical devices tremendously.11
Likewise, drugs with inadequate water solubility and/or 
dissolution rate along with hydrolytically medicines involve more 
complex development techniques in BNC, nevertheless provide a vast 
area for applications which has still to be studied.41 Another issue to 
take account is toxicity, BNC reveals absolutely no side effects as 
well as genotoxicity in vitro.41 The toxin levels of bacterial cellulose 
nanofibres have been effectively examined in vitro via cell viability 
and also flow cytometric assays along with in vivo choosing mice 
surgeries.42 Also, bacterial cellulose exhibits absolutely no side effects 
in the human being umbilical vein endothelial cell culture, fibroblasts, 
as well as chondrocytes.43 The in vitro analysis additionally reveals 
that 95% of the mesenchymal stem cells accumulate to cellulose 
membrane.18 Also, hydrophobic ally modified celluloses are GRAS 
materials that are widely used as excipients in the pharmaceutical 
industry.44,45 Even though BNC has been demonstrated as nongenotoxic 
and noncytotoxic, further studies are required to completely address 
such issue.46
Conclusion
Nan celluloses are natural materials with at least one dimension in 
the nano-scale.47,48 they combine important cellulose properties with 
the features of nanomaterials and open new horizons for materials 
science and its applications. Its everyday life use could be profitable 
in fields of practical application particularly as a product packaging, 
papers as well as paperboard, food products factory, health care and 
additionally sanitation products, paints, cosmetics, and so on. BNC 
are highly promising platforms for the synthesis of biocompatible 
nanocarriers of small molecule and macromolecular drugs for 
biomedical applications.49 The various processing procedures for BNC 
have already been fully optimized for many years, and good strategies 
that possibly focus on a more significant scale are being established.50 
Around the globe, research groups and, increasingly, companies are 
extensively working to expand the market for nanocellulose products 
and to open up totally new application areas. Key aspects for future 
development include the design of nanocelluloses for specific user 
requirements, the reduction of production costs, and the customization/
functionalization using post production steps and different types of 
compounding/processing.
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